Estradiol valerate/methenmadinone caproate

Estradiol valerate /
methenmadinone caproate
Estradiol valerate (top) and
methenmadinone caproate (bottom)
Combination of
Estradiol valerateEstrogen
Methenmadinone caproateProgestogen
Clinical data
Other namesEV/MMC; Lutofollin
Routes of
administration		Intramuscular injection
Identifiers
CAS Number

Estradiol valerate/methenmadinone caproate (EV/MMC), known by the tentative brand name Lutofollin, is a combination medication of estradiol valerate (EV), an estrogen, and methenmadinone caproate (MMC; superlutin caproate), a progestin, which was developed for potential use as a once-a-month combined injectable contraceptive but was never marketed. It contained 10 mg EV and 60 mg MMC in 1 mL oil solution and was intended for administration by intramuscular injection once every 4 weeks.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.